Navigation Links
Puritan Awarded New Canadian Patent for PurFlock® Ultra Flocked Swab
Date:7/9/2013

Guilford, ME (PRWEB) July 09, 2013

Puritan Medical Products, a leading manufacturer of flocked swabs, announced today that it has been granted a new Canadian patent for its high-performance PurFlock® Ultra flocked swab.

The latest Canadian patent (No. 2744678) is the sixth specimen collection device patent that Puritan has been awarded worldwide.

“The Canadian patents for our flocked swabs are a testament to Puritan's celebrated innovation in the single-use specimen collection microbiology transport market," said Puritan EVP of Global Sales Timothy Templet. “With our sixth patent, Puritan continues to expand our position as a global leader in the invention and manufacture of high-performance flocked swabs for specimen collection and transport.”

By combining a unique microstructure with cutting-edge fibers, Puritan’s PurFlock® Ultra and HydraFlock® swabs provide superior sample collection, rapid elution, and increased test sensitivity. Both flocked swabs are used in bacterial and viral transport systems and have been globally validated with automated systems and manual laboratory testing practices.

A Canadian device and method patent (No. 2744282) has been previously awarded for the HydraFlock® swab. Puritan has also received U.S. patents for the HydraFlock® swab (No. 8334134) and the PurFlock® Ultra (No. 8420385). In June, Puritan received two European patents for the PurFlock® Ultra (No. 2263549) and HydraFlock® flocked swabs (No. 2263548).

Puritan has expanded rapidly over the last few years as a direct result of the company’s effort to meet the evolving needs of the microbiology, healthcare, forensic, critical environment, food safety, and drug manufacturing industries.

Today, Puritan manufactures more than 35 types of specimen collection devices including the newly patented flocked swabs or media-filled transport systems. Puritan’s on-site state-of-the-art microbiology laboratory conforms to stringent U.S. quality system regulations. All research and development, product testing, approval and release take place at Puritan's facility in Guilford, ME.

About Puritan
Puritan Medical Products Co, LLC is North America’s largest manufacturer of single-use medical and diagnostics products. All products are manufactured at their Guilford, ME, U.S. facility, which includes custom media manufacturing and compounding capability to meet a multitude of customer needs.

Media Contact
Timothy Templet
Puritan Medical Products
sales(at)puritanmedproducts(dot)com
+1.207.876.331

Read the full story at http://www.prweb.com/releases/Puritan/FlockedSwabPatentCanada/prweb10905951.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Puritan Awarded U.S. Patent for High-Performance HydraFlock® Swab
2. Puritan Medical Products Launches New Series to Tell Customer Stories
3. K computer research results awarded ACM Gordon Bell Prize
4. BioPower Systems Awarded $5 Million from Victorian Government
5. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
6. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
7. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
8. Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research
9. EUR 1.0 Million Grant Awarded to Exosome Diagnostics and Ludwig Maximilian University from German Federal Ministry for Education and Research to Develop Biofluid-Derived Exosome Diagnostics
10. Sloan Research Fellowships Awarded to 126 Young Scholars
11. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
(Date:3/22/2017)... Florida , March 22, 2017 ... ... various cancer conditions are being pressured as of late due ... for cancer pain management has a dramatic impact on patient,s ... research and development activities for identifying new forms of opioid ...
(Date:3/22/2017)... , ... March 21, 2017 , ... Okyanos Cell Therapy ... as part of their live events series, “Stem Cell Therapy: The Next Phase in ... under the 2013 Stem Cell Research and Therapy Act, Okyanos maintains a ...
Breaking Biology Technology:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
Breaking Biology News(10 mins):